OQROGet OQRO Pro
Insider trade

Arcutis Biotherapeutics (ARQT)Director sold ~$94K

Terrie Curran, Director at Arcutis Biotherapeutics, sold ~$94K of Arcutis Biotherapeutics shares.

~$94K
Approx. value · 8,687 sh @ $10.85
10K
Holds after · shares reported
Traded
Nov 11, 2024
Filed
Nov 13, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2024InsiderDirector sold ~$93K of ARQT shares in the open market
  2. Oct 2, 2024InsiderOfficer sold ~$37K of ARQT shares in the open market
  3. Nov 1, 2024InsiderDirector sold ~$87K of ARQT shares in the open market
  4. Nov 4, 2024Insider · 3 peopleInsiders: 3 sales (~$298K)
  5. Nov 11, 2024 · this disclosureInsiderDirector sold ~$94K of ARQT shares in the open market

What came next

  1. Nov 14, 2024Insider · 1 personInsiders: 2 sales (~$712K)
  2. Nov 15, 2024InsiderOfficer sold ~$1K of ARQT shares in the open market
  3. Nov 19, 2024InsiderOfficer sold ~$17K of ARQT shares in the open market
  4. Nov 22, 2024InsiderOfficer sold ~$163K of ARQT shares in the open market
  5. Dec 2, 2024InsiderDirector sold ~$125K of ARQT shares in the open market
  6. Dec 20, 2024InsiderDirector sold ~$228K of ARQT shares in the open market
  7. Dec 31, 2024InsiderOfficer sold ~$24K of ARQT shares in the open market
  8. Jan 2, 2025InsiderDirector sold ~$147K of ARQT shares in the open market
  9. Feb 3, 2025Insider · 5 peopleInsiders: 5 sales (~$660K)
  10. Mar 3, 2025Insider · 4 peopleInsiders: 4 sales (~$481K)
  11. Mar 4, 2025Insider · 2 peopleInsiders: 2 sales (~$68K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Arcutis Biotherapeutics

For Arcutis Biotherapeutics, OQRO holds 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ARQT page.

Other recent filings by Terrie Curran, Director

The full history of Terrie Curran, Director is on the profile page.

How this filing works

Other disclosures at Arcutis Biotherapeutics

Everything OQRO holds on this company is on its ARQT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data